Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Minerva Neuroscie
(NQ:
NERV
)
2.210
+0.090 (+4.25%)
Streaming Delayed Price
Updated: 3:11 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Minerva Neuroscie
< Previous
1
2
3
4
5
6
Next >
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
November 05, 2024
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
August 06, 2024
NERV stock results show that Minerva Neurosciences missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
August 06, 2024
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
May 01, 2024
NERV stock results show that Minerva Neurosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Minerva Neurosciences: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Minerva Neurosciences Inc. (NASDAQ: NERV) Near the Top of Equities by Percentage Gain on 6/28
June 28, 2023
Via
Investor Brand Network
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
May 01, 2024
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
February 27, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data
February 27, 2024
Minerva Neurosciences faces FDA challenges for roluperidone in schizophrenia treatment. Understand the clinical deficiencies and potential paths forward. Cash position at December 31, 2023, around...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 27, 2024
Via
Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
February 27, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Nasdaq Rises 50 Points; Lowe's Earnings Top Views
February 27, 2024
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 39,043.13 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
February 27, 2024
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
February 22, 2024
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
February 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
November 07, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
August 01, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More
July 18, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Top 5 Health Care Stocks That May Collapse This Quarter
July 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
June 30, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...
Via
Benzinga
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
June 29, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
June 29, 2023
Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.
Via
Benzinga
Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations
June 28, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.32% to 33,818.48 while the NASDAQ rose 0.23% to 13,586.93. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 28, 2023
Via
Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 28, 2023
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
Via
Benzinga
Nasdaq Moves Higher; US Crude Stocks Drop More than Projected
June 28, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.